Arcalyst

Active Ingredient(s): Rilonacept
FDA Approved: * February 27, 2008
Pharm Company: * REGENERON PHARMACEUTICALS
Category: Anti-Inflammatory

Rilonacept, sold under the brand name Arcalyst, is a medication used to treat cryopyrin-associated periodic syndromes, including familial cold autoinflammatory syndrome, and Muckle–Wells syndrome; deficiency of interleukin-1 receptor antagonist; and recurrent pericarditis.[1][2][3] Rilonacept is an interleukin 1 inhibitor.[4] Rilonacept is a dimeric fusion protein consisting of the ligand-binding domains of the extracellula... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Arcalyst 160 mg/2ml Subcutaneous Injection, Powder, Lyophilized, for Solution
NDC: 61755-001
Labeler:
Regeneron Pharmaceuticals, Inc.